<< Report on the global biosimilars market | $4.5 million cost involved for MLSIC set up >>
Read in | English | Español | Français | Deutsch | Português | Italiano | 日本語 | 한국어 | 简体中文 | 繁體中文 | Nederlands | Русский | Svenska | Polski

Reportlinker offers a new report on the pharmaceutical market in Russia

Published on September 25, 2009 at 7:17 AM · No Comments

Reportlinker.com announces that a new market research report is available in its catalogue.

Pharmaceutical Markets in Russia

http://www.reportlinker.com/p0109222/Pharmaceutical-Markets-in-Russia.html

The pharmaceutical market in Russia ranks among the top twenty markets in the world with the potential to move up in ranking rather quickly. This market will be one of several that major pharmaceutical companies are exploring for new opportunities for growth. Reliance on commodity prices makes Russia's economy and government spending on healthcare variable, but awareness of healthcare issues, especially among the younger population, and a willingness to spend personal funds on healthcare will drive Russian markets.

For the purpose of this study six general segments are listed with a final segment including all other drug classes not listed. The specific segments outlined include:

Comments
The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.



  Country flag

biuquote
  • Comment
  • Preview
Loading